1. Response to Comment on Francés et al. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, Obesity, and Insulin Resistance. Diabetes 2015;64:1522–1531
    Ángela M. Valverde et al, 2015, Diabetes CrossRef
  2. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver
    Yutaka Takahashi, 2017, International Journal of Molecular Sciences CrossRef
  3. Cellular Senescence and Their Role in Liver Metabolism in Health and Disease: Overview and Future Directions
    Matthew Schade et al, 2018, Hepatocellular Carcinoma - Advances in Diagnosis and Treatment CrossRef
  4. Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma
    Mengna Wu et al, 2020, Current Molecular Pharmacology CrossRef
  5. Influence of 3D Microgrooves on C2C12 Cell Proliferation, Migration, Alignment, F-actin Protein Expression and Gene Expression
    Huichang Gao et al, 2016, Journal of Materials Science & Technology CrossRef
  6. Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
    Alessandra Caligiuri et al, 2021, Cells CrossRef
  7. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
    Devaraj Ezhilarasan et al, 2018, Hepatobiliary & Pancreatic Diseases International CrossRef
  8. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice
    Omar Motiño et al, 2016, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  9. Inhibition of pro-collagen I expression by oxymatrine in hepatic stellate cells is mediated via nuclear translocation of Y-box binding protein 1
    MEILING DU et al, 2015, Molecular Medicine Reports CrossRef
  10. Cellular senescence and liver disease: Mechanisms and therapeutic strategies
    Mei Guo, 2017, Biomedicine & Pharmacotherapy CrossRef
  11. Hepatic stellate cells as key target in liver fibrosis
    Takaaki Higashi et al, 2017, Advanced Drug Delivery Reviews CrossRef
  12. Reversal of liver fibrosis: From fiction to reality
    Miguel Eugenio Zoubek et al, 2017, Best Practice & Research Clinical Gastroenterology CrossRef
  13. Effect of celecoxib against different developmental stages of experimental Schistosoma mansoni infection
    Iman Fathy Abou-El-Naga et al, 2021, Acta Tropica CrossRef
  14. The potential role of senescence in limiting fibrosis caused by aging
    Xinghua Meng et al, 2020, Journal of Cellular Physiology CrossRef
  15. Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
    Cyril Sobolewski et al, 2021, Biomolecules CrossRef
  16. Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?
    Yau-Tuen Chan et al, 2020, Frontiers in Pharmacology CrossRef
  17. Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis
    Jaiwoo Lee et al, 2022, Nature Communications CrossRef